In addition, Sevim et al. investigated mTOR activation in livedo reticularis in patients with SLE and found increased mTOR activity in skin samples from both the central and peripheral areas of livedo lesions in aPL-positive patients [14]. This evidence concerns the gene MTOR and systemic lupus erythematosus.